首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

Current Oncology

Current Oncology杂志,由Multimed Inc.出版,于1994年创刊,Bimonthly,出版语言English,ISSN:1198-0052,E-ISSN:1718-7729。

投稿咨询
Current Oncology
Current Oncology
Current Oncology
SCI SCIE

杂志介绍

JCR分区
Q2
中科院分区
3区
影响因子
3.6
CiteScore
6.1
期刊收录
SCI、SCIE

Current Oncology(中文译名:《当前的肿瘤学》),ISSN:1198-0052,EISSN:1718-7729,是Multimed Inc.出版的国际性学术期刊,创刊于1994年,以Bimonthly形式稳定发行,2026年总发文量约718篇。该刊采用非OA开放访问,学科归属为ONCOLOGY。该刊是医学、肿瘤学领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达3.6,2025年期刊CiteScore为6.1,2025年期刊自引率约2.8%,在中科院期刊分区体系中位列医学大类3区,在所属学科领域具备高学术影响力与国际认可度。Current Oncology长期聚焦医学、肿瘤学及相关产业的技术应用前沿,平均审稿周期约1.0个月,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、肿瘤学领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,CanadaUSA、CHINA MAINLAND、England、Australia、Belgium、France等为核心发文国家与地区;UNIVERSITY OF TORONTOUNIVERSITY OF OTTAWA、MCMASTER UNIVERSITY、UNIVERSITY OF CALGARY、MCGILL UNIVERSITY、SUNNYBROOK HEALTH SCIENCE CENTER、UNIVERSITY OF BRITISH COLUMBIA等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
ONCOLOGY 肿瘤学
3区

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
ONCOLOGY 肿瘤学
4区

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
4区
ONCOLOGY 肿瘤学
4区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q2 132 / 333

60.5

学科:ONCOLOGY SCIE Q3 174 / 333

47.9

2024-2025年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q2 118 / 328

64.2

学科:ONCOLOGY SCIE Q3 174 / 328

47.1


中国学者近期发文

1
A Rare Case of Descending Colon Metastasis Following Radical Nephroureterectomy for Left Ureteral Carcinoma: A Case Report and Literature Revie

Author:Zhang, Huaiwen; Liu, Heyang; Luo, Yousong; Li, Peizhe; Yang, Lianjun; Shi, Jing; Duan, Junyao; Yan, Yongji

Journal: CURRENT ONCOLOGY. 2026; Vol. 33, Issue 4, pp. -. DOI: 10.3390/curroncol33040235

2
Acquired Resistance to Afatinib Mediated by EGFR T790M in Lung Adenocarcinoma Patients Harboring EGFR-KDD: A Case Report and Literature Revie

Author:Liu, Qian; Lv, Lu; Pang, Guanchao; Wang, Pingli

Journal: CURRENT ONCOLOGY. 2026; Vol. 33, Issue 4, pp. -. DOI: 10.3390/curroncol33040214

3
Lattice Radiation Therapy Plays a Synergistic Role in the Radical Treatment of Bulky Cervical Cancer: A Case Report and Literature Revie

Author:Wang, Feifei; Zhan, Qianru; Dai, Zhitao; Zhang, Huijuan; Peng, Miao; Chen, Zhijian; Jin, Jing; Sheng, Xiugui

Journal: CURRENT ONCOLOGY. 2026; Vol. 33, Issue 4, pp. -. DOI: 10.3390/curroncol33040196

4
E2F1-Driven WDHD1 Transcription Enhances Cell-Cycle Progression and Promotes Pancreatic Cancer Progressio

Author:Yang, Xiaojuan; Zhang, Zhiwei; Lv, Shuangjuan; Zhang, Buzhe; Tao, Xue; Liu, Chang; Zhu, Qing

Journal: CURRENT ONCOLOGY. 2026; Vol. 33, Issue 4, pp. -. DOI: 10.3390/curroncol33040186

5
Hepatitis B Virus Infection Is Associated with a Higher Risk of Liver Metastasis in Gastric Cance

Author:Zhu, Songting; Jiang, Mengmeng; Chen, Yanyan; Ding, Yongfeng; Wang, Haiyong; Teng, Lisong

Journal: CURRENT ONCOLOGY. 2026; Vol. 33, Issue 3, pp. -. DOI: 10.3390/curroncol33030179

6
Comparative Efficacy and Safety of First-Line Immune Checkpoint Inhibitors Plus Chemotherapy with or Without Bevacizumab in Advanced Non-Squamous Non-Small Cell Lung Carcinom

Author:Chen, Ping; Wang, Mengchi; Peng, Siyan; Zhu, Honglin; Wang, Yanming; Wan, Zixuan; Yang, Xuan; Yu, Zhixin; Zhou, Yixin

Journal: CURRENT ONCOLOGY. 2026; Vol. 33, Issue 3, pp. -. DOI: 10.3390/curroncol33030173

7
Current Applications and Future Directions of Artificial Intelligence in Prostate Cancer Diagnosis: A Narrative Revie

Author:Zhu, Cong-Yi; Qu, Rui; Dai, Yi; Yang, Luo

Journal: CURRENT ONCOLOGY. 2026; Vol. 33, Issue 3, pp. -. DOI: 10.3390/curroncol33030166

8
Neutrophil Extracellular Traps in Cancer Metastasis: From Mechanistic Understanding to Targeted Therap

Author:Tian, Xiaorui; Na, Jintong; Tan, Xinyi; Dang, Fengqiu; Zhu, Rui; Zhong, Liping; Zhao, Yongxiang

Journal: CURRENT ONCOLOGY. 2026; Vol. 33, Issue 3, pp. -. DOI: 10.3390/curroncol33030156

9
Molecular Mechanisms of Juvenile Nasopharyngeal Angiofibroma: A Narrative Revie

Author:Liu, Xingchen; Hu, Junying; Gan, Weigang; Liu, Feng; Zhong, Bing

Journal: CURRENT ONCOLOGY. 2026; Vol. 33, Issue 3, pp. -. DOI: 10.3390/curroncol33030147

10
Deep Learning-Derived Pathomic Features Predict NCIT Efficacy in Resectable Locally Advanced ESCC: Clinical Utility and Mechanistic Insight

Author:Zhu, Kunrui; Tong, Jie; Duan, Yaqi; Li, Yiming; Feng, Yanqi; Han, Yuelin; Xiao, Xiangtian; Han, Zhuoyan; Xia, Shu

Journal: CURRENT ONCOLOGY. 2026; Vol. 33, Issue 3, pp. -. DOI: 10.3390/curroncol33030136


在线咨询

Current Oncology

国际简称:CURR ONCOL参考译名:当前的肿瘤学

年发文量:718 CiteScore:6.1 是否预警:否 Gold OA文章占比:99.90% 研究类文章占比:71.87%

杂志社联系方式:MULTIMED INC, 66 MARTIN ST, TORONTO, CANADA, ON, L9T 2R2

Current Oncology